Last year, ASN President Susan E. Quaggin, MD, FASN, and I alternated sending monthly email updates to ASN members. Drafting these updates helped us put individual activities—such as the society's commitment to justice, equity, diversity, and inclusion—into a broader context. This year, we’re excited to publish these updates as editorials in ASN Kidney News.
2022 marks Dr. Quaggin's 33rd year as a member of ASN. “Over this period, it has been amazing to witness the growth and impact of our programs, which are driving innovation and positive changes in education, research, and patient care,” she told me recently. “I am so proud to be a member of a society and a community that puts patients first—always. I know that together, we can—and we will—make great strides to reach our shared vision of a world without kidney diseases.”
During the past decade, ASN has evolved from a membership society to the ASN Alliance for Kidney Health. In addition to ASN, the alliance includes:
KidneyCure, a foundation that spends more than $3 million annually to support trainees and early-career professionals
The Kidney Health Initiative (KHI), a partnership among ASN, the US Food and Drug Administration, and more than 100 member organizations to “catalyze innovation and the development of safe and effective patient-centered therapies for people living with kidney diseases”
The Kidney Innovation Accelerator (KidneyX), a partnership between ASN and the US Department of Health and Human Services that has funded more than 60 innovators to date
Nephrologists Transforming Dialysis Safety (NTDS), a partnership between ASN and the US Centers for Disease Control and Prevention that is the centerpiece of a broader effort to ensure excellence in patient care for the millions of people with kidney diseases
Last month, I summarized the alliance's accomplishments since January 2020 from “A to Z.” As part of this overview, I noted that the alliance has a new strategic plan that will guide us through December 2025.
To create the alliance's vision of “a world without kidney diseases,” we must work together to achieve our mission to “elevate care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.” Realizing this vision and mission requires us to accomplish five important goals.